Sanofi Achieves 7% Q3 Sales Growth Amid Product Launch Success

Paris, Friday, 24 October 2025.
Sanofi’s Q3 sales grew by 7%, driven by a 57.1% increase from new product launches, with Dupixent sales surpassing €4 billion for the first time, highlighting strong market performance.